Clinical Trial Update: YSPSL for Prevention of Ischemic Reperfusion Injury in Patients Undergoing Cadaveric Orthotopic Liver Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for YSPSL to prevent ischemia-reperfusion injury in patients undergoing cadaveric orthotopic liver transplantation; current stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemia-reperfusion Injury

Drugs mentioned

• YSPSL

Snippet

Sponsor: Y's Therapeutics, Inc. | Conditions: Ischemia Reperfusion Injury | Phase 2 | Status: UNKNOWN